Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2026 Earnings Call Transcript May 7, 2026
Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.93, expectations were $-1.09504.
Operator: Ladies and gentlemen, welcome to the Arrowhead Pharmaceuticals Conference Call. [Operator Instructions] I will now hand the conference call over to Vince Anzalone, Senior Vice President of Investor Relations for Arrowhead. Please go ahead, Vince.
Vincent Anzalone: Good afternoon,...
